Adverum Enterprise Value vs Tangible Asset Value Analysis

ADVM Stock  USD 14.66  0.51  3.60%   
Trend analysis of Adverum Biotechnologies balance sheet accounts such as Short Long Term Debt Total of 63.9 M, Other Current Liabilities of 13.1 M or Total Current Liabilities of 15 M provides information on Adverum Biotechnologies' total assets, liabilities, and equity, which is the actual value of Adverum Biotechnologies to its prevalent stockholders. By breaking down trends over time using Adverum Biotechnologies balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.

About Adverum Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Adverum Biotechnologies at a specified time, usually calculated after every quarter, six months, or one year. Adverum Biotechnologies Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Adverum Biotechnologies and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Adverum currently owns. An asset can also be divided into two categories, current and non-current.

Adverum Biotechnologies Balance Sheet Chart

Adverum Biotechnologies Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Adverum Biotechnologies uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Adverum Biotechnologies' Non Current Liabilities Total is very stable compared to the past year. As of the 28th of March 2024, Property Plant And Equipment Gross is likely to grow to about 85.6 M, while Total Current Liabilities is likely to drop about 15 M.

Total Assets

Total assets refers to the total amount of Adverum Biotechnologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Adverum Biotechnologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Adverum Biotechnologies balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Adverum Biotechnologies are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Adverum Biotechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Adverum Biotechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.As of the 28th of March 2024, Selling General Administrative is likely to drop to about 31.8 M. In addition to that, Tax Provision is likely to grow to about (1 M)
 2021 2022 2023 2024 (projected)
Total Operating Expenses153.6M157.1M121.7M81.4M
Cost Of Revenue4.6M6.5M5.6M5.4M

Adverum Biotechnologies fundamental ratios Correlations

0.630.260.740.940.180.65-0.06-0.610.560.350.66-0.520.940.460.730.60.640.820.650.610.940.310.120.430.84
0.630.680.840.38-0.050.890.32-0.830.350.070.9-0.530.390.50.530.930.60.80.930.920.410.710.580.840.33
0.260.680.69-0.02-0.30.570.29-0.820.350.020.57-0.230.01-0.150.180.670.440.610.620.680.020.890.940.840.06
0.740.840.690.55-0.120.880.3-0.890.720.060.89-0.430.550.220.660.840.830.950.910.840.560.720.50.760.47
0.940.38-0.020.550.320.42-0.27-0.330.480.460.42-0.471.00.40.720.310.490.660.420.331.0-0.01-0.130.110.82
0.18-0.05-0.3-0.120.32-0.31-0.760.23-0.130.74-0.28-0.230.350.04-0.11-0.25-0.18-0.1-0.21-0.30.34-0.28-0.18-0.32-0.03
0.650.890.570.880.42-0.310.55-0.80.47-0.181.0-0.340.410.540.690.950.70.840.990.960.420.640.390.790.43
-0.060.320.290.3-0.27-0.760.55-0.40.15-0.910.540.31-0.30.210.230.540.240.250.480.56-0.280.410.170.490.03
-0.61-0.83-0.82-0.89-0.330.23-0.8-0.4-0.570.03-0.810.34-0.34-0.2-0.37-0.88-0.73-0.89-0.84-0.88-0.36-0.91-0.68-0.94-0.46
0.560.350.350.720.48-0.130.470.15-0.570.030.47-0.320.48-0.080.530.380.90.650.470.360.490.370.120.340.36
0.350.070.020.060.460.74-0.18-0.910.030.03-0.17-0.530.49-0.03-0.03-0.140.030.1-0.1-0.170.48-0.080.09-0.120.15
0.660.90.570.890.42-0.281.00.54-0.810.47-0.17-0.340.410.540.690.960.70.850.990.960.430.650.40.790.43
-0.52-0.53-0.23-0.43-0.47-0.23-0.340.310.34-0.32-0.53-0.34-0.48-0.2-0.22-0.34-0.37-0.4-0.37-0.32-0.48-0.27-0.21-0.31-0.35
0.940.390.010.551.00.350.41-0.3-0.340.480.490.41-0.480.380.690.310.480.660.410.331.00.01-0.10.120.82
0.460.5-0.150.220.40.040.540.21-0.2-0.08-0.030.54-0.20.380.460.520.250.330.510.50.39-0.05-0.160.270.37
0.730.530.180.660.72-0.110.690.23-0.370.53-0.030.69-0.220.690.460.520.560.650.640.550.70.050.020.220.5
0.60.930.670.840.31-0.250.950.54-0.880.38-0.140.96-0.340.310.520.520.630.80.960.990.320.780.530.910.39
0.640.60.440.830.49-0.180.70.24-0.730.90.030.7-0.370.480.250.560.630.80.70.60.50.50.230.570.38
0.820.80.610.950.66-0.10.840.25-0.890.650.10.85-0.40.660.330.650.80.80.870.810.670.660.430.730.65
0.650.930.620.910.42-0.210.990.48-0.840.47-0.10.99-0.370.410.510.640.960.70.870.960.430.690.470.820.4
0.610.920.680.840.33-0.30.960.56-0.880.36-0.170.96-0.320.330.50.550.990.60.810.960.340.780.540.90.43
0.940.410.020.561.00.340.42-0.28-0.360.490.480.43-0.481.00.390.70.320.50.670.430.340.03-0.090.130.82
0.310.710.890.72-0.01-0.280.640.41-0.910.37-0.080.65-0.270.01-0.050.050.780.50.660.690.780.030.780.940.2
0.120.580.940.5-0.13-0.180.390.17-0.680.120.090.4-0.21-0.1-0.160.020.530.230.430.470.54-0.090.780.77-0.08
0.430.840.840.760.11-0.320.790.49-0.940.34-0.120.79-0.310.120.270.220.910.570.730.820.90.130.940.770.29
0.840.330.060.470.82-0.030.430.03-0.460.360.150.43-0.350.820.370.50.390.380.650.40.430.820.2-0.080.29
Click cells to compare fundamentals

Adverum Biotechnologies Account Relationship Matchups

Adverum Biotechnologies fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets222.7M482.6M439.7M308.4M173.0M247.9M
Other Current Liab2.6M1.3M2.0M16.8M12.5M13.1M
Total Current Liabilities19.4M20.9M21.3M32.2M24.9M15.0M
Total Stockholder Equity175.0M434.3M316.2M181.5M83.5M79.3M
Other Liab1.4M48K1.1M1.0M942.3K895.2K
Property Plant And Equipment Net45.8M47.1M119.1M113.9M67.0M37.4M
Net Debt(33.6M)(31.7M)68.8M38.4M36K37.8K
Retained Earnings(385.0M)(502.5M)(648.1M)(802.6M)(919.8M)(873.8M)
Accounts Payable4.1M2.8M1.4M2.2M1.9M1.9M
Cash65.9M62.4M34.2M68.4M75M78.2M
Non Current Assets Total46.9M48.1M122.6M117.8M70.2M39.7M
Cash And Short Term Investments166.0M429.7M305.2M185.6M96.5M91.7M
Common Stock Shares Outstanding64.1M85.1M98.0M99.3M10.1M9.6M
Liabilities And Stockholders Equity222.7M482.6M439.7M308.4M173.0M247.9M
Non Current Liabilities Total28.4M27.3M102.2M94.6M64.6M67.9M
Other Current Assets9.8M4.7M6.2M5.0M6.2M4.0M
Other Stockholder Equity560.7M937.1M965.0M985.7M1.0B567.3M
Total Liab47.8M48.2M123.5M126.9M89.5M46.9M
Property Plant And Equipment Gross24.9M47.1M132.2M130.9M81.5M85.6M
Total Current Assets175.9M434.4M317.1M190.6M102.8M97.6M
Accumulated Other Comprehensive Income(725K)(261K)(714K)(1.5M)(473K)(496.7K)
Property Plant Equipment24.9M27.7M33.1M113.9M130.9M137.5M
Non Currrent Assets Other11K29K250K1.4M1.2M1.3M
Other Assets1.0M1.0M3.5M3.9M4.5M4.7M
Net Tangible Assets175.0M434.3M316.2M181.5M208.7M256.7M
Common Stock Total Equity5K6K7K10K11.5K6.5K
Retained Earnings Total Equity(320.5M)(385.0M)(502.5M)(648.1M)(583.3M)(554.1M)
Short Term Investments100.1M367.3M271.0M117.2M21.5M20.4M
Capital Surpluse522.5M560.7M937.1M965.0M1.1B599.6M
Short Term Debt4.0M4.5M1.9M13.2M10.4M6.1M
Common Stock5K6K7K10K11.5K7.4K
Non Current Liabilities Other28.4M27.3M102.2M1.0M1.2M1.1M
Net Invested Capital175.0M434.3M316.2M181.5M83.5M79.3M
Net Working Capital156.5M413.6M295.8M158.3M77.9M74.0M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Adverum Biotechnologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Adverum Biotechnologies' short interest history, or implied volatility extrapolated from Adverum Biotechnologies options trading.

Pair Trading with Adverum Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adverum Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Adverum Stock

  0.74EQ Equillium Financial Report 9th of May 2024 PairCorr

Moving against Adverum Stock

  0.75VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.75CALT Calliditas Therapeutics Financial Report 21st of May 2024 PairCorr
  0.66MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.56MGTX MeiraGTx Holdings PLC Financial Report 9th of May 2024 PairCorr
  0.56PFE Pfizer Inc Fiscal Quarter End 31st of March 2024 PairCorr
The ability to find closely correlated positions to Adverum Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adverum Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adverum Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adverum Biotechnologies to buy it.
The correlation of Adverum Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adverum Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adverum Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adverum Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Adverum Stock analysis

When running Adverum Biotechnologies' price analysis, check to measure Adverum Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adverum Biotechnologies is operating at the current time. Most of Adverum Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adverum Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adverum Biotechnologies' price. Additionally, you may evaluate how the addition of Adverum Biotechnologies to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Is Adverum Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.60)
Revenue Per Share
0.357
Quarterly Revenue Growth
(0.70)
Return On Assets
(0.32)
Return On Equity
(0.88)
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.